vs
Astrana Health, Inc.（ASTH）与NetApp（NTAP）财务数据对比。点击上方公司名可切换其他公司
NetApp的季度营收约是Astrana Health, Inc.的1.8倍（$1.7B vs $950.5M），NetApp净利率更高（19.5% vs 0.7%，领先18.8%），Astrana Health, Inc.同比增速更快（42.9% vs 4.4%），NetApp自由现金流更多（$271.0M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 1.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
NetApp是总部位于美国加利福尼亚州圣何塞的企业级数据基础设施服务商，成立于1992年，2012至2021年连续入选《财富》世界500强。公司面向全球企业客户提供统一数据存储、集成数据服务及云运营解决方案，可满足线上线下全场景的应用与数据管理需求。
ASTH vs NTAP — 直观对比
营收规模更大
NTAP
是对方的1.8倍
$950.5M
营收增速更快
ASTH
高出38.5%
4.4%
净利率更高
NTAP
高出18.8%
0.7%
自由现金流更多
NTAP
多$276.9M
$-6.0M
两年增速更快
ASTH
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.7B |
| 净利润 | $6.6M | $334.0M |
| 毛利率 | — | 70.6% |
| 营业利润率 | 1.9% | 25.3% |
| 净利率 | 0.7% | 19.5% |
| 营收同比 | 42.9% | 4.4% |
| 净利润同比 | 184.4% | 11.7% |
| 每股收益（稀释后） | $0.12 | $1.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHNTAP
| Q1 26 | — | $1.7B | ||
| Q4 25 | $950.5M | $1.7B | ||
| Q3 25 | $956.0M | $1.6B | ||
| Q2 25 | $654.8M | $1.7B | ||
| Q1 25 | $620.4M | $1.6B | ||
| Q4 24 | $665.2M | $1.7B | ||
| Q3 24 | $478.7M | $1.5B | ||
| Q2 24 | $486.3M | $1.7B |
净利润ASTHNTAP
| Q1 26 | — | $334.0M | ||
| Q4 25 | $6.6M | $305.0M | ||
| Q3 25 | $373.0K | $233.0M | ||
| Q2 25 | $9.4M | $340.0M | ||
| Q1 25 | $6.7M | $299.0M | ||
| Q4 24 | $-7.8M | $299.0M | ||
| Q3 24 | $16.1M | $248.0M | ||
| Q2 24 | $19.2M | $291.0M |
毛利率ASTHNTAP
| Q1 26 | — | 70.6% | ||
| Q4 25 | — | 72.0% | ||
| Q3 25 | — | 70.4% | ||
| Q2 25 | — | 68.9% | ||
| Q1 25 | — | 69.8% | ||
| Q4 24 | — | 71.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 70.5% |
营业利润率ASTHNTAP
| Q1 26 | — | 25.3% | ||
| Q4 25 | 1.9% | 23.4% | ||
| Q3 25 | 2.0% | 19.8% | ||
| Q2 25 | 3.1% | 20.1% | ||
| Q1 25 | 3.3% | 22.1% | ||
| Q4 24 | 0.1% | 20.8% | ||
| Q3 24 | 5.9% | 18.3% | ||
| Q2 24 | 6.2% | 21.9% |
净利率ASTHNTAP
| Q1 26 | — | 19.5% | ||
| Q4 25 | 0.7% | 17.9% | ||
| Q3 25 | 0.0% | 14.9% | ||
| Q2 25 | 1.4% | 19.6% | ||
| Q1 25 | 1.1% | 18.2% | ||
| Q4 24 | -1.2% | 18.0% | ||
| Q3 24 | 3.4% | 16.1% | ||
| Q2 24 | 3.9% | 17.4% |
每股收益（稀释后）ASTHNTAP
| Q1 26 | — | $1.67 | ||
| Q4 25 | $0.12 | $1.51 | ||
| Q3 25 | $0.01 | $1.15 | ||
| Q2 25 | $0.19 | $1.64 | ||
| Q1 25 | $0.14 | $1.44 | ||
| Q4 24 | $-0.14 | $1.42 | ||
| Q3 24 | $0.33 | $1.17 | ||
| Q2 24 | $0.40 | $1.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $3.0B |
| 总债务越低越好 | — | $2.5B |
| 股东权益账面价值 | $779.3M | $1.2B |
| 总资产 | $2.2B | $10.0B |
| 负债/权益比越低杠杆越低 | — | 2.15× |
8季度趋势，按日历期对齐
现金及短期投资ASTHNTAP
| Q1 26 | — | $3.0B | ||
| Q4 25 | $429.5M | $3.0B | ||
| Q3 25 | $463.4M | $3.3B | ||
| Q2 25 | $342.1M | $3.8B | ||
| Q1 25 | $260.9M | $2.3B | ||
| Q4 24 | $290.8M | $2.2B | ||
| Q3 24 | $350.3M | $3.0B | ||
| Q2 24 | $327.7M | $3.3B |
总债务ASTHNTAP
| Q1 26 | — | $2.5B | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $3.2B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B |
股东权益ASTHNTAP
| Q1 26 | — | $1.2B | ||
| Q4 25 | $779.3M | $986.0M | ||
| Q3 25 | $775.5M | $975.0M | ||
| Q2 25 | $765.5M | $1.0B | ||
| Q1 25 | $745.4M | $995.0M | ||
| Q4 24 | $712.7M | $892.0M | ||
| Q3 24 | $704.6M | $929.0M | ||
| Q2 24 | $678.9M | $1.1B |
总资产ASTHNTAP
| Q1 26 | — | $10.0B | ||
| Q4 25 | $2.2B | $9.6B | ||
| Q3 25 | $2.2B | $9.7B | ||
| Q2 25 | $1.4B | $10.8B | ||
| Q1 25 | $1.3B | $9.0B | ||
| Q4 24 | $1.4B | $9.0B | ||
| Q3 24 | $1.3B | $9.3B | ||
| Q2 24 | $1.3B | $9.9B |
负债/权益比ASTHNTAP
| Q1 26 | — | 2.15× | ||
| Q4 25 | — | 2.52× | ||
| Q3 25 | — | 2.55× | ||
| Q2 25 | — | 3.11× | ||
| Q1 25 | — | 2.00× | ||
| Q4 24 | — | 2.23× | ||
| Q3 24 | — | 2.58× | ||
| Q2 24 | — | 2.09× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $317.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $271.0M |
| 自由现金流率自由现金流/营收 | -0.6% | 15.8% |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 0.95× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHNTAP
| Q1 26 | — | $317.0M | ||
| Q4 25 | $-2.9M | $127.0M | ||
| Q3 25 | $10.0M | $673.0M | ||
| Q2 25 | $90.9M | — | ||
| Q1 25 | $16.6M | $385.0M | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | $341.0M | ||
| Q2 24 | $23.2M | $613.0M |
自由现金流ASTHNTAP
| Q1 26 | — | $271.0M | ||
| Q4 25 | $-6.0M | $78.0M | ||
| Q3 25 | $7.4M | $620.0M | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | $338.0M | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | $300.0M | ||
| Q2 24 | $20.4M | $567.0M |
自由现金流率ASTHNTAP
| Q1 26 | — | 15.8% | ||
| Q4 25 | -0.6% | 4.6% | ||
| Q3 25 | 0.8% | 39.8% | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | 20.6% | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | 19.5% | ||
| Q2 24 | 4.2% | 34.0% |
资本支出强度ASTHNTAP
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.9% | ||
| Q3 25 | 0.3% | 3.4% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | 2.9% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | 2.7% | ||
| Q2 24 | 0.6% | 2.8% |
现金转化率ASTHNTAP
| Q1 26 | — | 0.95× | ||
| Q4 25 | -0.44× | 0.42× | ||
| Q3 25 | 26.69× | 2.89× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 1.29× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.38× | ||
| Q2 24 | 1.21× | 2.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
NTAP
| Services | $927.0M | 54% |
| Product | $786.0M | 46% |
